Links between hypertension and myocardial infarction

American Heart Journal

Volumn 132, Issue 1 II, 1996, Pages 213-221

  Rakugi, H ^a   Yu, H ^a   Kamitani, A ^a   Nakamura, Y ^a   Ohishi, M ^a   Kamide, K ^a   Nakata, Y ^a   Takami, S ^a   Higaki, J ^a   Ogihara, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CONFERENCE PAPER; CORONARY RISK; DISEASE ASSOCIATION; HEART INFARCTION; HYPERTENSION; INSULIN RESISTANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SYMPATHETIC TONE;

EID: 15844399875     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90556-6     Document Type: Conference Paper

References (67)

1. MacMahon S Peto R Cutler J Collins R Sorlie P Neaton J Abbott R Godwin J Dyer A Stamler J Blood pressure, stroke, and coronary heart disease. Part I: Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 33 1990 765 774
2. Neaton JD Wentworth D Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men: Multiple Risk Factor Intervention Trial Research Group Arch Intern Med 152 1992 56 64
3. Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
4. Sumpio BE Widmann MD Ricotta J Awolesi MA Watase M Increased ambient pressure stimulates proliferation and morphologic changes in cultured endothelial cells J Cell Physiol 158 1994 133 139
5. The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions N Engl J Med 327 1992 685 691
6. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
7. Pfeffer MA Braunwald E Moye LA Basta L Brown EJ Jr Cuddy TE Davis BR Geltman EM Goldman S Flaker GC Klein M Lamas GA Packer M Rouleau J Rouleau JL Rutherford J Wertheimer JH Hawkins CM on behalf of the SAVE investigators Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial: The SAVE Investigators N Engl J Med 327 1992 669 677
8. Hata A Namikawa C Sasaki M Sato K Nakamura T Tamura K Lalouel JM Angiotensinogen as a risk factor for essential hypertension in Japan J Clin Invest 93 1994 1285 1287
9. Jeunemaitre X Soubrier F Kotelevtsev YV Lifton RP Willjams CS Charru A Hunt SC Hopkins PN Williams RR Lalouel JM Corvol P Molecular basis of human hypertension: role of angiotensinogen Cell 71 1992 169 180
10. Kamitani A Rakugi H Higaki J Yi Z Mikami H Miki T Ogihara T Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese J Hum Hypertens 8 1994 521 524
11. Nishimura S Kario K Kayaba K Nagio N Shimada K Matsuo T Matsuo M Effect of the angiotensinogen gene Met235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations J Hypertens 13 1995 717 722
12. Iwai N Shimoike H Ohmichi N Kinoshita M Angiotensinogen gene and blood pressure in the Japanese population Hypertension 25 1995 688 693
13. Ishigami T Umemura S Iwamoto T Tamura K Hibi K Yamaguchi S Nyuui N Kimura K Miyazaki N Ishii M Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis Circulation 91 1995 951 954
14. Katsuya T Koike G Yee TW Sharpe N Jackson R Norton R Horiuchi M Pratt RE Dzau VJ MacMahon S Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease Lancet 345 1995 1600 1603
15. Kamitani A Rakugi H Higaki J Ohishi M Shi S-J Takami S Nakata Y Higashino Y Fujii K Mikami H Miki T Ogihara T Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis Hypertension 25 1995 950 953
16. Rigat B Hubert C Alhenc Gelas F Cambien F Corvol P Soubrier F An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
17. Costerousse O Allegrini J Lopez M Alhenc Gelas F Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes Biochem J 290 1993 33 40
18. Cambien F Poirier O Lecerf L Evans A Cambou JP Arveiler D Luc G Bard JM Bara L Ricard S Tiret L Amouyel P Alhenc-Gelas F Soubrier F Deletion polymorphism in the gene for angiotensinconverting enzyme is a potent risk factor for myocardial infarction Nature 359 1992 641 644
19. Ludwig E Corneli PS Anderson JL Marshall HW Lalouel JM Ward RH Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis Circulation 91 1995 2120 2124
20. Zhao Y Higashimori K Higaki J Kamitani A Ohishi M Katsuya T Miki T Mikami H Minamino T Ogihara T Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese Hypertens Res 17 1994 55 57
21. Lindpaintner K Pfeffer MA Kreutz R Stampfer MJ Grodstein F La-Motte F Buring J Hennekens CH A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease N Engl J Med 332 1995 706 711
22. Hillis G Al-Mohammad A Jennings K Angiotensin-converting enzyme genotype and ischemic heart disease N Engl J Med 333 1995 458 460
23. Ohishi M Rakugi H Higaki J Miki T Ogihara T Angiotensinconverting enzyme genotype and ischemic heart disease N Engl J Med 333 1995 458 460
24. Tiret L Bonnardeaux A Poirier O Ricard S Marques Vidal P Evans A Arveiler D Luc G Kee F Ducimetiere P Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction Lancet 344 1994 910 913
25. Epstein M Sowers JR Diabetes mellitus and hypertension Hypertension 19 1992 403 418
26. Flack JM Sowers JR Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia Am J Med 91 1991 11s 21s
27. Ferrannini E Buzzigoli G Bonadonna R Giorico MA Oleggini M Graziadei L Pedrinelli R Brandi L Bevilacqua S Insulin resistance in essential hypertension N Engl J Med 317 1987 350 357
28. Modan M Halkin H Almog S Lusky A Eshkol A Shefi M Shitrit A Fuchs Z Hyperinsulinemia: a link between hypertension obesity and glucose intolerance J Clin Invest 75 1985 809 817
29. Kaplan NM The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension Arch Intern Med 149 1989 1514 1520
30. Reaven GM Banring lecture 1988: role of insulin resistance in human disease Diabetes 37 1988 1595 1607
31. Sowers JR Standley PR Ram JL Jacober S Simpson L Rose K Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis Am J Hypertens 6 1993 260s 270s
32. Sowers JR Khoury S Standley P Zemel P Zemel M Mechanisms of hypertension in diabetes Am J Hypertens 4 1991 177 182
33. Standicy PR Zhang F Ram JL Zemel MB Sowers JR Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells J Clin Invest 88 1991 1230 1236
34. Kamide K Nagano M Nakano N Kobayashi R Higfiki J Mikami H Ogihara T Role of insulin resistance in cardiovascular hypertrophy in patients with essential hypertension [abstract] Am J Hypertens 8 1995 51A
35. Julius S Pascual AV London R Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension Circulation 44 1971 413 418
36. Esler M Julius S Zweifler A Randall O Harburg E Gardiner H De-Quattro V Mild high-renin essential hypertension: Neurogenic human hypertension? N Engl J Med 296 1977 405 411
37. Esler M Jennings G Biviano B Lambert G Hasking G Mechanism of elevated plasma noradrenaline in the course of essential hypertension J Cardiovasc Pharmacol 8 suppl 5 1986 S39 S43
38. Julius S Sympathetic hyperactivity and coronary risk in hypertension Hypertension 21 1993 886 893
39. Folkow B Role of the vascular factor in hypertension Contrib Nephrol 8 1977 81 94
40. Areann FW Bolli P Kiowski W Buhler FR Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertension Hypertension 3 1981 1119 1123
41. Nakamaru M Jackson EK Inagami T Role of vascular angiotensin II released by beta-adrenergic stimulation in rats J Cardiovasc Pharmacol 8 suppl 10 1986 S1 S5
42. Nakamaru M Jackson EK Inagami T Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries Am J Physiol 250 1986 H144 H148
43. Tabuchi Y Nakamaru M Rakugi H Nagano M Higashimori K Mikami H Ogihara T Effects of endothelin on neuroeffector junction in mesenteric arteries of hypertensive rats Hypertension 15 1990 739 743
44. Ito M Oliverio MI Mannon PJ Best CF Maeda N Smithies O Coffman TM Regulation of blood pressure by the type 1A angiotensin II receptor gene Proc Natl Acad Sci U S A 92 1995 3521 3525
45. Bayhash AG Hosoda K Giaid A Richardson JA Emoto N Hammer RE Yanagisawa M Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons Cell 79 1994 1277 1285
46. Hosoda K Hammer RE Richardson JA Bayhash AG Cheung JC Giaid A Yanagisawa M Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice Cell 79 1994 1267 1276
47. Tanimoto K Sugiyama F Goto Y Ishida J Takimoto E Yagami K Fukamizu A Murakami K Angiotensinogen-deficient mice with hypotension J Biol Chem 269 1994 31334 31337
48. Griffin SA Brown WC MacPherson F McGrath JC Wilson VG Korsgaard N Mulvany MJ Lever AF Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism Hypertension 17 1991 626 635
49. Morishita R Higaki J Nakamura F Tomita N Yu H Nagano M Mikami H Ogihara T Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat Blood Press Suppl 3 1992 41 47
50. Morishita R Higaki J Miyazaki M Ogihara T Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy Hypertension 19 1992 1162 1167
51. Yu H Rakugi H Higaki J Morishita R Mikami H Ogihara T The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats J Hypertens 11 1993 1347 1355
52. Powell JS Clozel JP Muller RK Kuhn H Hefti F Hosang M Baumgartner HR Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury Science 245 1989 186 188
53. Dzau VJ Re R Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation 89 1994 493 498
54. Rakugi H Jacob HJ Krieger JE Ingelfinger JR Pratt RE Vascular injury induces angiotensinogen gene expression in the media and neointima Circulation 87 1993 283 290
55. Rakugi H Kim DK Krieger JE Wang DS Dzau VJ Pratt RE Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis J Clin Invest 93 1994 339 346
56. Rakugi H Wang DS Dzau VJ Pratt RE Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation Circulation 1994 449 455
57. Ohishi M Ueda M Rakugi H Higaki J Naruko T Becker AE Ogihara T Enhanced expression of angiotensin converting enzyme is associated with the progression of atherosclerosis in human coronary arteries [abstract] Hypertension 26 1995 539
58. O'Rourke M Mechanical principles in arterial disease Hypertension 26 1995 2 9
59. Fishel R Shai S Norc K Endothelial cell angiotensin converting enzyme expression is upregulated by fluid shear stress [abstract] FASEB J 5 1991 A1247
60. Resnick N Collins T Atkinson W Bonthron DT Dewey CF Jr Gimbron MA Jr Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element Proc Natl Acad Sci U S A 90 1993 4591 4595
61. Hishikawa K Nakaki T Suzuki H Saruta T Kato R Transmural pressure inhibits nitric oxide release from human endothelial cells Eur J Pharmacol 215 1992 329 331
62. Hishikawa K Nakaki T Marumo T Suzuki H Kato R Saruta T Pressure enhances endothelin-1 release from cultured human endothelial cells Hypertension 25 1995 449 452
63. Hishikawa K Nakaki T Marumo T Hayashi M Suzuki H Kato R Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells J Clin Invest 93 1994 1975 1980
64. (part 2) Nakamura Y Rakugi H Higaki J Inoue T Fukuo K Mikami H Ogihara T Pulsatile stretch on smooth muscle and endothelial cells plays an important role in the growth of smooth muscle cells Circulation 88 1993 I 184
65. Kobayashi R Nagano M Nakamura F Higaki J Fujioka Y Ikegami H Mikami H Kawaguchi N Onishi S Ogihara T Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats Hypertension 21 1993 1051 1055
66. Ohishi M Rakugi H Ogihara T Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy N Engl J Med 331 1994 1097 1098
67. Schunkert H Hense HW Holmer SR Stender M Perz S Keil U Lorell BH Riegger GA Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy N Engl J Med 330 1994 1634 1638